hyaluronoglucosaminidase has been researched along with Blindness in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (9.09) | 18.7374 |
1990's | 1 (3.03) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 13 (39.39) | 24.3611 |
2020's | 16 (48.48) | 2.80 |
Authors | Studies |
---|---|
Ayton, T; Dalgliesh, JD; Danks, JJ | 1 |
Goodman, GJ | 1 |
Dao, HX; Duong, QH; Le, DT; Nguyen, HH; Nguyen, MD; Tran, HTT | 1 |
Navarro-Hernandez, E; Pérez-López, M | 1 |
Gu, Q; Pan, L; Shi, H; Sun, Y; Wu, S; Xu, H; Zhang, L; Zhou, Q | 1 |
Feng, X; Shi, H; Wu, S; Wu, WTL; Zhang, L | 1 |
Bai, XY; Chen, ML; Dai, Q; Lai, LY; Liang, LM; Tang, WQ; Yu, YT; Zhang, LX; Zhou, GW; Zhou, YC | 1 |
DeLorenzi, C | 2 |
Hwang, CJ; Perry, JD | 1 |
Lee, W; Yang, EJ | 1 |
Milman, T; Paap, MK; Silkiss, RZ; Ugradar, S | 2 |
Fagien, S | 2 |
Li, J; Liu, Z; Luo, Z; Wu, M; Wu, S; Xu, H; Zhang, L | 1 |
Grow, JN; Zins, JE | 1 |
Diniz, S; Goldberg, RA; Hoenig, J; Ugradar, S | 1 |
Chen, M; Dong, Y; Fu, Q; Liang, L; Xu, X; Yu, Y; Zhang, L; Zhou, G | 1 |
Chesnut, C | 1 |
Durkin, S; Halliday, L; Selva, D; Sia, PI | 1 |
Chang, FC; Chen, SJ; Chen, YC; Guo, WY; Lee, HJ; Lin, CJ; Lirng, JF; Luo, CB; Wu, HM | 1 |
Jones, DH | 1 |
Raimbault, C | 1 |
Pan, L; Sun, Y; Wu, S; Wu, WTL; Xu, H; Yan, S; Zhang, L | 1 |
Perry, JD; Said, SA; Surek, CC; Zins, JE | 1 |
Kapoor, KM; Philipp-Dormston, WG; Wibowo, A | 1 |
Kim, KW; Ko, HS; Lee, SY; Lee, W; Oh, W; Yang, EJ | 1 |
Carruthers, A; Carruthers, JDA; Fagien, S; Rohrich, RJ; Weinkle, S | 1 |
CASTIGLIONE, J; LIJOPAVIA, JJ; MARCONI, GA | 1 |
Boghen, D; Hamel, P | 1 |
Bryant, JA | 1 |
Krüger, KE | 1 |
6 review(s) available for hyaluronoglucosaminidase and Blindness
Article | Year |
---|---|
Effectiveness of retrobulbar hyaluronidase in the treatment of visual loss caused by periocular hyaluronic acid injection. A systematic review.
Topics: Animals; Blindness; Dermal Fillers; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intraocular; Vision Disorders | 2022 |
Intra-Arterial Thrombolytic Therapy Is Not a Therapeutic Option for Filler-Related Central Retinal Artery Occlusion.
Topics: Angiography; Blindness; Dermal Fillers; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Infusions, Intra-Arterial; Retinal Artery Occlusion; Treatment Failure; Urokinase-Type Plasminogen Activator; Young Adult | 2018 |
[What's new in interventional dermatology?]
Topics: Blindness; Botulinum Toxins, Type A; Cicatrix, Hypertrophic; Dermal Fillers; Dermatology; Embolism; Facial Muscles; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections; Lasers, Dye; Melanosis; Necrosis; Neurotoxins; Port-Wine Stain; Skin Aging; Tranexamic Acid; Viscosupplements | 2018 |
Retrobulbar Injection for Hyaluronic Acid Gel Filler-Induced Blindness: A Review of Efficacy and Technique.
Topics: Blindness; Cosmetic Techniques; Dermal Fillers; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intralesional; Male; Prognosis; Recovery of Function; Risk Assessment; Treatment Outcome | 2019 |
Blindness caused by cosmetic filler injection: a review of cause and therapy.
Topics: Biocompatible Materials; Blindness; Cosmetic Techniques; Durapatite; Embolism; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intradermal; Subcutaneous Fat; Tissue Transplantation | 2014 |
Local and topical anesthetics in ophthalmology.
Topics: Absorption; Anesthesia, Local; Anesthetics, Local; Autonomic Nerve Block; Barbiturates; Blindness; Cardiovascular System; Central Nervous System; Cornea; Drug Hypersensitivity; Drug Synergism; Drug Tolerance; Eye; Eye Diseases; Humans; Hyaluronoglucosaminidase; Neurologic Manifestations; Oxygen Inhalation Therapy; Succinylcholine; Synaptic Transmission; Vasoconstrictor Agents | 1969 |
27 other study(ies) available for hyaluronoglucosaminidase and Blindness
Article | Year |
---|---|
Cosmetic Filler Blindness: Recovery After Repeated Hyaluronidase Injections.
Topics: Adult; Blindness; Cosmetic Techniques; Cosmetics; Dermal Fillers; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections; Ischemia; Retinal Artery Occlusion | 2022 |
Commentary on: Cosmetic Filler Blindness: Recovery After Repeated Hyaluronidase Injections.
Topics: Blindness; Cosmetics; Dermal Fillers; Humans; Hyaluronoglucosaminidase | 2022 |
Significant Vision Recovery from Filler-Induced Complete Blindness with Combined Intra-Arterial Injection of Hyaluronidase and Thrombolytic Agents.
Topics: Adult; Blindness; Cosmetic Techniques; Dermal Fillers; Female; Fibrinolytic Agents; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intra-Arterial | 2022 |
Long-term Prognosis of Vision Loss Caused by Facial Hyaluronic Acid Injections and the Potential Approaches to Address This Catastrophic Event.
Topics: Blindness; Cosmetic Techniques; Dermal Fillers; Face; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Prognosis | 2023 |
Blindness After Facial Filler Injections: The Role of Extravascular Hyaluronidase on Intravascular Hyaluronic Acid Embolism in the Rabbit Experimental Model.
Topics: Animals; Blindness; Dermal Fillers; Embolism; Hyaluronic Acid; Hyaluronoglucosaminidase; Models, Theoretical; Rabbits | 2020 |
Evaluation of Intraarterial Thrombolysis in Treatment of Cosmetic Facial Filler-Related Ophthalmic Artery Occlusion.
Topics: Adult; Angiography, Digital Subtraction; Blindness; Cosmetic Techniques; Dermal Fillers; Drug Therapy, Combination; Embolism; Eye; Female; Follow-Up Studies; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intra-Arterial; Injections, Subcutaneous; Male; Ophthalmic Artery; Retrospective Studies; Thrombolytic Therapy; Treatment Outcome; Urokinase-Type Plasminogen Activator; Visual Acuity | 2020 |
Commentary on: Blindness After Facial Filler Injections: The Role of Extravascular Hyaluronidase on Intravascular Hyaluronic Acid Embolism in the Rabbit Experimental Model.
Topics: Animals; Blindness; Dermal Fillers; Embolism; Hyaluronic Acid; Hyaluronoglucosaminidase; Models, Theoretical; Rabbits | 2020 |
Effectiveness of Retrobulbar Hyaluronidase Injection in an Iatrogenic Blindness Rabbit Model Using Hyaluronic Acid Filler Injection.
Topics: Animals; Blindness; Dermal Fillers; Hyaluronic Acid; Hyaluronoglucosaminidase; Iatrogenic Disease; Rabbits | 2020 |
Reply: Effectiveness of Retrobulbar Hyaluronidase Injection in an Iatrogenic Blindness Rabbit Model Using Hyaluronic Acid Filler Injection.
Topics: Animals; Blindness; Dermal Fillers; Hyaluronic Acid; Hyaluronoglucosaminidase; Iatrogenic Disease; Rabbits | 2020 |
Discussion: Assessing Retrobulbar Hyaluronidase as a Treatment for Filler-Induced Blindness in a Cadaver Model and Video Discussion: Treatment for Filler-Induced Blindness.
Topics: Blindness; Cadaver; Dermal Fillers; Humans; Hyaluronoglucosaminidase; Orbit | 2020 |
Reply: Video Discussion: Assessing Retrobulbar Hyaluronidase as a Treatment for Filler-Induced Blindness in a Cadaver Model.
Topics: Blindness; Cadaver; Dermal Fillers; Humans; Hyaluronoglucosaminidase; Orbit | 2020 |
Endovascular Hyaluronidase Application Through Superselective Angiography to Rescue Blindness Caused by Hyaluronic Acid Injection.
Topics: Angiography; Blindness; Dermal Fillers; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase | 2021 |
Commentary on: Endovascular Hyaluronidase Application Through Superselective Angiography to Rescue Blindness Caused by Hyaluronic Acid Injection.
Topics: Angiography; Blindness; Dermal Fillers; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase | 2021 |
Generation of Filler Emboli as a Mechanism for Filler-Related Blindness.
Topics: Blindness; Cosmetic Techniques; Dermal Fillers; Durapatite; Embolism; Face; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intradermal; Models, Anatomic; Ophthalmic Artery; Regional Blood Flow; Skin | 2021 |
Efficacy of intra-arterial thrombolytic therapy for vision loss resulting from hyaluronic acid filler embolization.
Topics: Animals; Blindness; Dermal Fillers; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Thrombolytic Therapy | 2021 |
Restoration of Visual Loss With Retrobulbar Hyaluronidase Injection After Hyaluronic Acid Filler.
Topics: Adult; Blindness; Cosmetic Techniques; Dermal Fillers; Embolism; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections; Orbit; Recovery of Function | 2018 |
Atypical case of hyaluronidase allergy with orbital compartment syndrome and visual loss.
Topics: Blindness; Compartment Syndromes; Drug Hypersensitivity; Humans; Hyaluronoglucosaminidase; Magnetic Resonance Imaging; Male; Middle Aged; Orbit; Orbital Diseases; Tomography, X-Ray Computed | 2018 |
Update on Emergency and Nonemergency Use of Hyaluronidase in Aesthetic Dermatology.
Topics: Blindness; Cosmetic Techniques; Dermal Fillers; Emergencies; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Necrosis; Peripheral Vascular Diseases; Skin | 2018 |
Clinical Observations and the Anatomical Basis of Blindness After Facial Hyaluronic Acid Injection.
Topics: Adult; Blindness; Dermal Fillers; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intralesional; Injections, Subcutaneous; Prognosis; Rejuvenation; Retinal Artery Occlusion; Retrospective Studies; Risk Assessment; Sampling Studies; Treatment Outcome; Young Adult | 2019 |
Reversal of Post-filler Vision Loss and Skin Ischaemia with High-Dose Pulsed Hyaluronidase Injections.
Topics: Adult; Blindness; Cosmetic Techniques; Dermal Fillers; Female; Follow-Up Studies; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Ischemia; Nose; Pulse Therapy, Drug; Recovery of Function; Risk Assessment; Severity of Illness Index; Skin; Treatment Outcome | 2019 |
Effectiveness of Retrobulbar Hyaluronidase Injection in an Iatrogenic Blindness Rabbit Model Using Hyaluronic Acid Filler Injection.
Topics: Animals; Blindness; Carotid Artery, Internal; Dermal Fillers; Disease Models, Animal; Electroretinography; Fluorescein Angiography; Hyaluronic Acid; Hyaluronoglucosaminidase; Iatrogenic Disease; Injections, Intra-Arterial; Rabbits; Reperfusion; Retinal Artery Occlusion | 2019 |
Discussion: Effectiveness of Retrobulbar Hyaluronidase Injection in an Iatrogenic Blindness Rabbit Model Using Hyaluronic Acid Filler Injection.
Topics: Animals; Blindness; Dermal Fillers; Hyaluronic Acid; Hyaluronoglucosaminidase; Iatrogenic Disease; Rabbits | 2019 |
Assessing Retrobulbar Hyaluronidase as a Treatment for Filler-Induced Blindness in a Cadaver Model.
Topics: Blindness; Cadaver; Dermal Fillers; Gels; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intraocular; Optic Nerve; Recombinant Proteins; Retinal Artery Occlusion | 2019 |
Discussion: Assessing Retrobulbar Hyaluronidase as a Treatment for Filler-Induced Blindness in a Cadaver Model.
Topics: Blindness; Cadaver; Dermal Fillers; Humans; Hyaluronoglucosaminidase; Orbit | 2019 |
[ATROPHY OF THE OPTIC NERVE: PROGNOSIS AND TREATMENT].
Topics: Acid Phosphatase; Arsenicals; Atrophy; Bismuth; Blindness; Gonadotropins; Humans; Hyaluronoglucosaminidase; Optic Atrophy; Optic Nerve; Prognosis; Retinal Vessels; Syphilis; Syphilis, Congenital; Visual Fields | 1964 |
Bilateral amaurosis following peribulbar anesthesia.
Topics: Aged; Anesthesia, Local; Anesthetics, Combined; Anesthetics, Local; Blindness; Bupivacaine; Glaucoma, Open-Angle; Humans; Hyaluronoglucosaminidase; Injections; Lidocaine; Male; Optic Nerve; Orbit; Tomography, X-Ray Computed; Ultrasonography, Doppler; Vitrectomy | 1998 |
[Temporary blindness following retrobulbar anesthesia].
Topics: Adult; Anesthesia, Local; Blindness; Humans; Hyaluronoglucosaminidase; Lidocaine; Male; Nystagmus, Pathologic; Postoperative Complications | 1966 |